Clinical trials
Phase 3 Multiple Myeloma trials in Bulgaria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Celgene Corporation | 1 |
| Centocor, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Oncopeptides AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 14 |
| Recurrence | 4 |
| Blood Protein Disorders | 1 |
| Bone Diseases | 1 |
| Bone Marrow Diseases | 1 |
| Bone Marrow Neoplasms | 1 |
| Bone Neoplasms | 1 |
| Fractures, Bone | 1 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.